Suven Pharmaceuticals Limited

Suven Pharmaceuticals Limited Share · INE03QK01018 (XNSE) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Suven Pharmaceuticals Limited
No Price
Closing Price XNSE 30.04.2026: 480,70 INR
30.04.2026 10:18
Current Prices from Suven Pharmaceuticals Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XBOM: MSE
MSE
COHANCE.BO
INR
30.04.2026 10:18
482,95 INR
-
XNSE: NSE
NSE
COHANCE.NS
INR
30.04.2026 10:00
480,70 INR
-
Share Float & Liquidity
Free Float 36,06 %
Shares Float 137,96 M
Shares Outstanding 382,57 M
Company Profile for Suven Pharmaceuticals Limited Share
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited. As of September 29, 2023, Suven Pharmaceuticals Limited operates as a subsidiary of Berhyanda Limited.

Company Data

Name Suven Pharmaceuticals Limited
Company Suven Pharmaceuticals Limited
Website https://www.suvenpharm.com
Primary Exchange XNSE NSE
ISIN INE03QK01018
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Sudhir Kumar Singh
Market Capitalization 412 Mrd.
Country India
Currency INR
Employees 2,6 T
Address # 8-2-334, SDE Serene Chambers, 500034 Hyderabad
IPO Date 2020-03-09
Dividends from 'Suven Pharmaceuticals Limited'
Ex-Date Dividend per Share
09.09.2022 6,00 INR
13.05.2022 2,00 INR
15.02.2022 2,00 INR
13.08.2021 1,00 INR
17.02.2021 1,00 INR

Stock Splits

Date Split
25.09.2020 2:1

Ticker Symbols

Name Symbol
MSE COHANCE.BO
MSE SUVENPHAR.BO
NSE COHANCE.NS
NSE SUVENPHAR.NS
More Shares
Investors who hold Suven Pharmaceuticals Limited also have the following shares in their portfolio:
DEKA IHS MTN S 7754
DEKA IHS MTN S 7754 Bond
FIRSTMARK HORIZON ACQUISITION CORP CLASS A
FIRSTMARK HORIZON ACQUISITION CORP CLASS A Share